{"entity":{"type":"insider","cik":"0001508231","url":"/insider/0001508231","json_url":"/insider/0001508231.json","name":"Fletcher Robert C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2012-03-12","last":"2020-01-14","span_basis":"filed_date"},"name_variants":[{"name":"Fletcher Robert C.","source":"filing","n_filings":3,"first_seen":"2012-03-12","last_seen":"2020-01-14"}],"transactions":[{"id":9242581,"accession":"0001179110-20-000559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-000559","line_url":"/filing/0001179110-20-000559#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001508231","owner_name":"Fletcher Robert C.","owner_display_name":"Fletcher Robert C.","owner_url":"/insider/0001508231","role":"Officer (Sr. VP, Bus. Dev. & Strategy)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Bus. Dev. & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Bus. Dev. & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1615.0,"shares_display":"1,615","price_per_share":1.7804,"price_display":"1.78","price_state":"stated","total_value":2875.346,"total_display":"2,875.35","total_whole":"2,875","shares_owned_after":16485.0,"shares_owned_after_display":"16,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-14","scope":"insider"},{"id":3186220,"accession":"0001179110-20-000447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-000447","line_url":"/filing/0001179110-20-000447#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":"0001508231","owner_name":"Fletcher Robert C.","owner_display_name":"Fletcher Robert C.","owner_url":"/insider/0001508231","role":"Officer (Sr. VP, Bus. Dev. & Strategy)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Bus. Dev. & Strategy)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Bus. Dev. & Strategy","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1615.0,"shares_display":"1,615","price_per_share":1.7804,"price_display":"1.78","price_state":"stated","total_value":2875.346,"total_display":"2,875.35","total_whole":"2,875","shares_owned_after":16485.0,"shares_owned_after_display":"16,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-07","filed_date":"2020-01-10","scope":"insider"},{"id":3115476,"accession":"0001127602-12-010407","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-12-010407","line_url":"/filing/0001127602-12-010407#line-4","is_derivative":false,"issuer_cik":"0000946840","issuer_name":"VIROPHARMA INC","issuer_ticker":"VPHM","issuer_name_source":null,"issuer_url":"/issuer/0000946840","owner_cik":"0001508231","owner_name":"Fletcher Robert C.","owner_display_name":"Fletcher Robert C.","owner_url":"/insider/0001508231","role":"Officer (V.P., Business Development)","role_mark":"O","role_mark_label":"Officer (V.P., Business Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"V.P., Business Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32000.0,"shares_display":"32,000","price_per_share":29.6548,"price_display":"29.65","price_state":"stated","total_value":948953.6,"total_display":"948,953.60","total_whole":"948,954","shares_owned_after":229.0,"shares_owned_after_display":"229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-09","filed_date":"2012-03-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Officer (Sr. VP, Bus. Dev. & Strategy)","n_filings":2,"first_seen":"2020-01-10","last_seen":"2020-01-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000946840","name":"VIROPHARMA INC","url":"/issuer/0000946840","role":"Officer (V.P., Business Development)","n_filings":1,"first_seen":"2012-03-12","last_seen":"2012-03-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001508231","retrieved_at":"2026-08-23T05:12:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}